Back to 
BNP Paribas Financial Markets
BNP Paribas Financial Markets
LGND
Showing 8 of 31 quarters
Position history for BNP Paribas Financial Markets's holdings in Ligand Pharmaceuticals Incorporated
Yes. BNP Paribas Financial Markets holds 94,072 shares of LGND (Ligand Pharmaceuticals), worth $29.7M, as of its Q2 2026 13F filing. It increased the position by 59,157 shares (+169.4%) from Q1 2026. BNP Paribas Financial Markets has held LGND in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$29.7M
Current Shares
94,072
Total Value Change
+$29.3M
Total Shares Change
+89,916
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.